Further, a cross sectional study investigating blood biomarkers involved in obesity and MetS in patients undergoing TKR for end stage OA did show a correlation between FABP4, leptin and resistin with obese females; these findings were independent of MetS and not associated with knee OA severity [59]. Here, FABP4 is linked to metabolic syndrome.